(Q44407158)

English

Cognitive Enhancing Properties and Tolerability of Cholinergic Agents in Mice: A Comparative Study of Nicotine, Donepezil, and SIB-1553A, a Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors

scientific article published on April 2, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Cognitive Enhancing Properties and Tolerability of Cholinergic Agents in Mice: A Comparative Study of Nicotine, Donepezil, and SIB-1553A, a Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors (English)

1 reference

10.1038/SJ.NPP.1300150

https://api.crossref.org/works/10.1038/SJ.NPP.1300150

25 December 2023

1 reference

ChEBI release 2020-05-28

1 reference

10.1038/SJ.NPP.1300150

https://api.crossref.org/works/10.1038/SJ.NPP.1300150

25 December 2023

author name string

Bruno Bontempi

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Frédérique Menzaghi

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kevin T. Whelan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700710

25 December 2023

Victoria B. Risbrough

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700710

25 December 2023

G. Kenneth Lloyd

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700710

25 December 2023

language of work or name

0 references

publication date

2 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

full work available at URL

https://www.nature.com/articles/1300150.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700710

25 December 2023

http://www.nature.com/articles/1300150.pdf

Portable Document Format

1 reference

10.1038/SJ.NPP.1300150

https://api.crossref.org/works/10.1038/SJ.NPP.1300150

25 December 2023

http://www.nature.com/articles/1300150

1 reference

10.1038/SJ.NPP.1300150

https://api.crossref.org/works/10.1038/SJ.NPP.1300150

25 December 2023

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1235-1246

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Nicotinic receptor abnormalities in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Adverse effects associated with the use of donepezil in general practice in England

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

The cholinergic hypothesis of Alzheimer's disease: a review of progress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Ageing: the cholinergic hypothesis of cognitive decline.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Tracking the cognitive pharmacodynamics of psychoactive substances with combinations of behavioral and neurophysiological measures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Donepezil therapy in clinical practice: a randomized crossover study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Cholinesterase inhibitors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Effects of diazepam and beta-CCM on working memory in mice: relationships with emotional reactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Nicotinic acetylcholine involvement in cognitive function in animals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Nicotinic acetylcholine receptors in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Nicotinic treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Clinical neurochemistry: developments in dementia research based on brain bank material

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Nicotinic receptor subtypes in human brain related to aging and dementia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Glucose attenuates the effect of combined muscarinic-nicotinic receptor blockade on spontaneous alternation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Cognitive effects of nicotine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Strategies that support declining cholinergic neurotransmission in Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Multiple parallel memory systems in the brain of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Nicotinic acetylcholine binding sites in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

The pharmacology of donepezil: a new treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

21 January 2018

Clinical pharmacology of nicotine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous alternation behavior.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

7 January 2021

based on heuristic

inferred from DOI database lookup

The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of fornix and caudate nucleus lesions on two radial maze tasks: evidence for multiple memory systems.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

7 January 2021

based on heuristic

inferred from DOI database lookup

Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrahippocampal infusions of k-atp channel modulators influence spontaneous alternation performance: relationships to acetylcholine release in the hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

7 January 2021

based on heuristic

inferred from DOI database lookup

Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300150

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300150

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44407158&oldid=2206626292"